These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 28705068

  • 1. Quantifying the Susceptibility Variation of Normal-Appearing White Matter in Multiple Sclerosis by Quantitative Susceptibility Mapping.
    Chen W, Zhang Y, Mu K, Pan C, Gauthier SA, Zhu W, Wang Y.
    AJR Am J Roentgenol; 2017 Oct; 209(4):889-894. PubMed ID: 28705068
    [Abstract] [Full Text] [Related]

  • 2. Quantitative Susceptibility Mapping and R2* Measured Changes during White Matter Lesion Development in Multiple Sclerosis: Myelin Breakdown, Myelin Debris Degradation and Removal, and Iron Accumulation.
    Zhang Y, Gauthier SA, Gupta A, Chen W, Comunale J, Chiang GC, Zhou D, Askin G, Zhu W, Pitt D, Wang Y.
    AJNR Am J Neuroradiol; 2016 Sep; 37(9):1629-35. PubMed ID: 27256856
    [Abstract] [Full Text] [Related]

  • 3. Quantitative susceptibility mapping of the normal-appearing white matter as a potential new marker of disability progression in multiple sclerosis.
    Pietroboni AM, Colombi A, Contarino VE, Russo FML, Conte G, Morabito A, Siggillino S, Carandini T, Fenoglio C, Arighi A, De Riz MA, Arcaro M, Sacchi L, Fumagalli GG, Bianchi AM, Triulzi F, Scarpini E, Galimberti D.
    Eur Radiol; 2023 Aug; 33(8):5368-5377. PubMed ID: 36562783
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Grey:white matter ratio at diagnosis and the risk of 10-year multiple sclerosis progression.
    Moccia M, Quarantelli M, Lanzillo R, Cocozza S, Carotenuto A, Carotenuto B, Alfano B, Prinster A, Triassi M, Nardone A, Palladino R, Brunetti A, Brescia Morra V.
    Eur J Neurol; 2017 Jan; 24(1):195-204. PubMed ID: 27801535
    [Abstract] [Full Text] [Related]

  • 6. Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis.
    Jurcoane A, Wagner M, Schmidt C, Mayer C, Gracien RM, Hirschmann M, Deichmann R, Volz S, Ziemann U, Hattingen E.
    J Magn Reson Imaging; 2013 Dec; 38(6):1454-61. PubMed ID: 23554005
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Metabolic Patterns in Chronic Multiple Sclerosis Lesions and Normal-appearing White Matter: Intraindividual Comparison by Using 2D MR Spectroscopic Imaging.
    Fleischer V, Kolb R, Groppa S, Zipp F, Klose U, Gröger A.
    Radiology; 2016 Nov; 281(2):536-543. PubMed ID: 27243371
    [Abstract] [Full Text] [Related]

  • 11. Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes.
    Pietroboni AM, Carandini T, Colombi A, Mercurio M, Ghezzi L, Giulietti G, Scarioni M, Arighi A, Fenoglio C, De Riz MA, Fumagalli GG, Basilico P, Serpente M, Bozzali M, Scarpini E, Galimberti D, Marotta G.
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):280-287. PubMed ID: 30343433
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. White Matter Tract Injury is Associated with Deep Gray Matter Iron Deposition in Multiple Sclerosis.
    Bergsland N, Tavazzi E, Laganà MM, Baglio F, Cecconi P, Viotti S, Zivadinov R, Baselli G, Rovaris M.
    J Neuroimaging; 2017 Jan; 27(1):107-113. PubMed ID: 27239049
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Normal appearing and diffusely abnormal white matter in patients with multiple sclerosis assessed with quantitative MR.
    West J, Aalto A, Tisell A, Leinhard OD, Landtblom AM, Smedby Ö, Lundberg P.
    PLoS One; 2014 Jan; 9(4):e95161. PubMed ID: 24747946
    [Abstract] [Full Text] [Related]

  • 20. (11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas.
    Park E, Gallezot JD, Delgadillo A, Liu S, Planeta B, Lin SF, O'Connor KC, Lim K, Lee JY, Chastre A, Chen MK, Seneca N, Leppert D, Huang Y, Carson RE, Pelletier D.
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1081-92. PubMed ID: 25833352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.